NCT05163392View on ClinicalTrials.gov

A Silver Lining in the VAD Sky

NAActive, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

December 1, 2024

Study Completion Date

June 30, 2025

Conditions
LVAD (Left Ventricular Assist Device) Driveline Infection
Interventions
DEVICE

Silverlon

SIlver-plated biopatch

DEVICE

Control

Tegaderm without biopatch

Trial Locations (1)

94143

UCSF Parnassus, San Francisco

All Listed Sponsors
collaborator

International Consortium of Circulatory Assist Clinicians

OTHER

lead

University of California, San Francisco

OTHER